These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10391762)

  • 1. Treating patients with severe sepsis.
    Meier-Hellmann A; Bredle DL; Reinhart K
    N Engl J Med; 1999 Jul; 341(1):56; author reply 57. PubMed ID: 10391762
    [No Abstract]   [Full Text] [Related]  

  • 2. An appraisal of selection and use of catecholamines in septic shock - old becomes new again.
    Myburgh JA
    Crit Care Resusc; 2006 Dec; 8(4):353-60. PubMed ID: 17227275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catecholamines and splanchnic perfusion.
    Meier-Hellmann A; Sakka SG; Reinhart K
    Schweiz Med Wochenschr; 2000 Dec; 130(50):1942-7. PubMed ID: 11189440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study.
    Sakr Y; Reinhart K; Vincent JL; Sprung CL; Moreno R; Ranieri VM; De Backer D; Payen D
    Crit Care Med; 2006 Mar; 34(3):589-97. PubMed ID: 16505643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine and dobutamine in septic shock. A comparison.
    Majerus TC; Chodoff P; Borel CO
    Arch Int Physiol Biochim; 1984 Nov; 92(4):S65-7. PubMed ID: 6085242
    [No Abstract]   [Full Text] [Related]  

  • 6. [Human recombinant activated protein C in patients with severe sepsis and septic shock].
    Segal E
    Harefuah; 2002 Feb; 141(2):130-1. PubMed ID: 11905079
    [No Abstract]   [Full Text] [Related]  

  • 7. The choice of catecholamines in septic shock: more and more good arguments to strengthen the known position, but don't lose the faith!
    Meier-Hellmann A
    Crit Care; 2006; 10(2):127. PubMed ID: 16563178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of dopamin (hydroxytyramine) in urosepsis of septic shock (author's transl)].
    Faul P; Engels E
    Urologe A; 1981 Mar; 20(2):98-101. PubMed ID: 7197075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial: Bacteraemic shock.
    Lancet; 1974 Feb; 1(7852):296-7. PubMed ID: 4130477
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of catecholamines on splanchnic perfusion in sepsis].
    Hernández G; Tomicic V
    Rev Med Chil; 1999 Jun; 127(6):719-27. PubMed ID: 10513083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [[Antithrombin III concentrates in the treatmetn of sepsis and septic shock: indictions, limits and future prospects] ].
    Baudo F; de Cataldo F
    Minerva Anestesiol; 2000 Nov; 66(11 Suppl 1):3-23. PubMed ID: 11213542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antithrombin III in severe sepsis and septic shock].
    Carrillo-Esper R; Núñez-Monroy FN
    Gac Med Mex; 1999; 135(4):443-6. PubMed ID: 10491905
    [No Abstract]   [Full Text] [Related]  

  • 13. Systemic and organ dysfunction response during infusion of recombinant human activated protein C (rhAPC) in severe sepsis and septic shock.
    Gullo A; Iscra F; Di Capua G; Berlot G; Lucangelo U; Peratoner A; Fasiolo S; Viviani M; Consales C; Zicari A
    Minerva Anestesiol; 2005 Dec; 71(12):785-801. PubMed ID: 16288186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sepsis in the critically-ill patient].
    Christensen VB; Nielsen JS; Tønnesen EK
    Ugeskr Laeger; 2007 Feb; 169(8):703-5. PubMed ID: 17313921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticosteroids in sepsis: a new concept for an old drug.
    Klaitman V; Almog Y
    Isr Med Assoc J; 2003 Jan; 5(1):51-5. PubMed ID: 12592960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [No documented therapeutic effect of immunoglobulin in severe sepsis and septic shock. Cochrane review is a shot that hit the post!].
    Gårdlund B; Sjölin J
    Lakartidningen; 2001 Dec; 98(49):5623-4. PubMed ID: 11783047
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study).
    Póvoa PR; Carneiro AH; Ribeiro OS; Pereira AC;
    Crit Care Med; 2009 Feb; 37(2):410-6. PubMed ID: 19114885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Short term effects of hypertonic saline during severe sepsis and septic shock].
    Muller L; Lefrant JY; Jaber S; Louart G; Mahamat A; Ripart J; de La Coussaye JE; Eledjam JJ
    Ann Fr Anesth Reanim; 2004 Jun; 23(6):575-80. PubMed ID: 15234722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety and efficacy of the use of vasopressin in sepsis and septic shock.
    Wilson SJ; Mehta SS; Bellamy MC
    Expert Opin Drug Saf; 2005 Nov; 4(6):1027-39. PubMed ID: 16255662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of protein C concentrate in adult patients with severe sepsis and septic shock].
    Baratto F; Michielan F; Gagliardi G; Di Gregorio G; Pasqualetto A; Meroni M; Giron GP
    Minerva Anestesiol; 2004 May; 70(5):351-6. PubMed ID: 15181415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.